AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $482,408 | +83506.2% | 62,086 | +4.1% | 0.03% | -8.8% |
| Q2 2023 | $577 | -67.0% | 59,621 | -62.6% | 0.03% | -68.2% |
| Q1 2023 | $1,748 | +145.5% | 159,509 | -3.2% | 0.11% | +143.2% |
| Q4 2022 | $712 | -100.0% | 164,811 | -45.4% | 0.04% | -70.5% |
| Q3 2022 | $2,269,000 | -24.2% | 301,685 | +1.2% | 0.15% | -19.9% |
| Q2 2022 | $2,995,000 | -8.9% | 298,048 | +12.2% | 0.19% | +6.3% |
| Q1 2022 | $3,288,000 | -46.8% | 265,598 | -1.6% | 0.18% | -42.2% |
| Q4 2021 | $6,175,000 | -0.7% | 270,005 | -3.9% | 0.30% | -7.3% |
| Q3 2021 | $6,217,000 | +87.0% | 280,921 | +9.5% | 0.33% | +84.7% |
| Q2 2021 | $3,325,000 | +47.5% | 256,543 | +47.8% | 0.18% | +31.1% |
| Q1 2021 | $2,254,000 | – | 173,560 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |